HDAC-IN-53
HDAC-IN-53 is an orally active, and selective HDAC1-3 inhibitor with IC50 values of 47 nM, 125 nM, and 450 nM, respectively. HDAC-IN-53 does not inhibit class II HDACs (HDAC4, 5, 6, 7, 9; IC50>10 μM) . HDAC-IN-53 induces caspase-dependent apoptosis. HDAC-IN-53 significantly inhibits the growth of human tumor xenografts in nude mice and murine tumor growth in immune-competent mice bearing MC38 colon cancer[1].
Product Specifications
CAS Number
2921948-27-6
UNSPSC
12352005
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-53.html
Purity
95.73
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=NN(C2=CC=CC=C2Cl)N=C1C(NCC3=CC=C(C=C3)C(NC4=CC=CC=C4N)=O)=O
Molecular Formula
C23H20ClN7O2
Molecular Weight
461.90
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
T-complex Protein 1 Subunit gamma, ID (CCT3, TCP-1-gamma, CCT-gamma, hTRiC5, TRIC5, CCTG) (HRP) discontinued
MEF2B sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)